<DOC>
	<DOCNO>NCT01267331</DOCNO>
	<brief_summary>This prospective , randomize , placebo-controlled study design assess safety , feasibility efficacy intramyocardial injection autologous bone marrow mononuclear cell patient severe , chronic ischemic disease schedule coronary artery bypass surgery .</brief_summary>
	<brief_title>Cell Therapy Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery</brief_title>
	<detailed_description>Severe ischemic heart disease remain clinical challenge ; many patient undergone surgical myocardial revascularization procedure , still remain symptomatic despite optimal medical therapy . Cell therapy autologous bone marrow-derived cell ( BMC ) novel therapeutic strategy test surgical treatment patient severe , chronic ischemic heart disease . This research study perform find information safety , feasibility , efficacy direct intramyocardial injection autologous BMC myocardial perfusion leave ventricular function adjunctive therapy ( compare placebo ) patient undergo coronary artery bypass surgery ( CABG ) . The heart function evaluation perform electrocardiogram , echocardiogram , cMRI baseline 6 month follow-up . The secondary objective study assess effect intramyocardial injection autologous BMC functional class ( angina/heart failure ) , global cardiovascular mortality , major adverse cardiac event undergo coronary artery bypass surgery .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<criteria>1 . Age 18 75 year . 2 . Scheduled undergo CABG . 3 . At least 3 month since last episode myocardial infarction . 4 . Echocardiogramassessed LVEF 15 40 % ( Simpson 's rule ) . 5 . Abnormal wall motion least one segment due prior myocardial infarction show echocardiography leave ventriculography . 6 . Abnormal myocardial perfusion infarcted area SPECT . 7 . Willingness participate ability provide write informed consent . 1 . Contraindications magnetic resonance imaging . 2 . Need urgent emergent revascularization . 3 . Severe valvular heart disease . 4 . Confirmed myocardial infarction within 14 day , and/or rise cardiac biomarker protein ( i.e . troponin ) , and/or worsen ECG change . 5 . Prior cardiac surgery . 6 . Stroke within 3 month prior CABG . 7 . Immunosuppressive medication ( e.g . prednisone , cyclophosphamide , etanercept , etc . ) 8 . Severe chronic renal insufficiency ( serum creatinine ≥ 200 mmol/dl need dialysis ) , liver disease , ( diagnosis cirrhosis , chronic hepatitis , elevation serum transaminases ≥3 time upper limit normal ) , cerebrovascular disease require concomitant carotid endarterectomy , peripheral arterial disease ( claudication primary factor limit activity ) , active nondermatological malignancy require ongoing treatment , condition would place patient increase risk complication judgment attend cardiologist cardiac surgeon 9 . Hemoglobin le 10g/dL , white blood cell count less 4,000/mm3 , absolute neutrophil count less 1500/mm3 10 . Active infection , temperature great 37.5°C within 48 hr prior surgery unexplained white blood cell count excess 10,000/mm3 11 . Significant cognitive impairment . 12 . Any condition associate life expectancy le 6 month . 13 . Participation study . 14 . Positive laboratory test result HIV , HBC , HCV . 15 . Pregnant woman . 16 . Inability unwillingness provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Old Myocardial Infarction</keyword>
	<keyword>Stem Cell Therapy</keyword>
	<keyword>Coronary Artery Bypass Grafting</keyword>
	<keyword>Coronary Artery Disease</keyword>
</DOC>